Back to search

Article

A Randomised Clinical Trial of Azithromycin Versus Standard Care in Ambulatory COVID-19 – The ATOMIC2 Trial

2021-04-15

Abstract excerpt

Background: The antibacterial, anti-inflammatory and antiviral properties of azithromycin suggest therapeutic potential against COVID-19. Randomised data in mild-moderate disease are lacking. We assessed whether azithromycin is effective in reducing hospitalisation in patients with mild-moderate COVID-19. <br><br>Methods: This open-label, randomised superiority clinical trial at 19 centres in the United Kingdom e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c2bfb967-4a3a-5f45-bca4-d0e70a8fa7a6
DOI
10.2139/ssrn.3827019
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Randomised Clinical Trial of Azithromycin Versus Standard Care in Ambulatory COVID-19 – The ATOMIC2 TrialDOI 10.2139/ssrn.3827019
Select a neighboring publication to make it the new centre.